Novel research suggests that 4FMA, a engineered copyright compound, might contain promising potential for therapeutic applications. While still in its developmental phase, studies have demonstrated that 4FMA can evoke intense copyright experiences, potentially rivaling those of more established psychedelics like LSD and copyright. Pioneers are cur